Patents/Assignees

Cnpharm Co., Ltd.

5 patents in portfolio

US12419961utility2025
Docetaxel-aconitic Anhydride Conjugate Exhibiting Anti-tumor Activity Without in Vivo Toxicity
0 cites
US12409229utility2025
Synthesizing Drug-organic-acid-anhydride Conjugates Without Using Coupling Reagent
0 cites
US11969440utility2024
Metal (hydr)oxide Composite Comprising Poorly Soluble Drug, Method for Manufacturing Same, and Pharmaceutical Composition Comprising Same
0 cites
US11912829utility2024
Cationic Polyphosphazene Compound, Polyphosphazenes-drug Conjugate Compound and Method for Preparing Same
0 cites
US8344173utility2013
Dendritic Oligopeptide-grafteded Cyclotriphosphazene, a Process for the Preparation Thereof and a Drug Delivery System Containing the Same
0 cites